SIRT1 and cardiomyopathy: Type 2 diabetes is accompanied by a decrease in the activation of SIRT1 and AMPK and by a striking suppression of autophagy [48–50]; these changes have been implicated in the myocardial injury and cardiomyopathy in type 2 diabetes [49–51].